F. Franceschi

Global Antibiotic Research & Development Partnership — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index5.9kcitations119works10.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA and protein synthesis mechanisms(51), RNA modifications and cancer(36), X-ray Diffraction in Crystallography(33), Crystallization and Solubility Studies(32), Crystallography and molecular interactions(27)

Publications119 total

Carbapenem-resistant Enterobacterales among patients with bloodstream infections in South Africa: Consolidated surveillance data, 2015–2021
PLoS ONE·2025· 4 citedOpen Access
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps
Antimicrobial Agents and Chemotherapy·2024· 17 citedOpen Access
Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model
Frontiers in Pharmacology·2023· 10 citedOpen Access
Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections
Frontiers in Pharmacology·2022· 26 citedOpen Access
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings
Journal of Antimicrobial Chemotherapy·2022· 7 citedOpen Access
30 Determining a potential alternative empirical antibiotic regimen for the treatment of neonatal sepsis in low- and middle-income settings using pre-clinical in vitro techniques
Clinical Infection in Practice·2022Open Access
Genomic surveillance and antimicrobial resistance in <i>Neisseria gonorrhoeae</i> isolates in Bangkok, Thailand in 2018
Journal of Antimicrobial Chemotherapy·2022· 16 cited
Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model
Frontiers in Pharmacology·2022· 32 citedOpen Access
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance
Journal of Antimicrobial Chemotherapy·2022· 24 citedOpen Access
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria
Pediatric Drugs·2021· 46 citedOpen Access
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies
BMC Infectious Diseases·2021· 33 citedOpen Access
Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model
Frontiers in Pharmacology·2021· 39 citedOpen Access
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
Clinical Microbiology and Infection·2021· 18 citedOpen Access
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance
Antimicrobial Agents and Chemotherapy·2021· 25 citedOpen Access
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli
International Journal of Antimicrobial Agents·2021· 103 citedOpen Access
Clinical Efficacy of Combination Therapy for the Treatment of Severe Infections Caused by Carbapenem Resistant Gram-Negatives. A Systematic Review of Clinical Studies
2021Open Access
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities
Clinical Microbiology and Infection·2020· 21 citedOpen Access
In vivo studies on antibiotic combination for the treatment ofcarbapenem-resistant Gram-negative bacteria: a systematic review andmeta-analysis protocolIn vivo studies on antibiotic combination for thetreatment of carbapenem-resistant Gram-negative bacteria: a systematicreview and meta-analysis protocol
BMJ Open Science·2020· 4 citedOpen Access
Accelerating global innovation to address antibacterial resistance: introducing CARB-X
Nature Reviews Drug Discovery·2016· 55 cited
Identification of Selected Ribosomal Components in Crystallographic Maps of Prokaryotic Ribosomal Subunits at Medium Resolution
ASM Press eBooks·2014· 7 cited
page 1 of 6Next →

Frequent Co-authors

Ada Yonath(24), Heike Bartels(13), Ilana Agmon(12), Harly A. S. Hansen(10), Frank Schlünzen(9), J. Harms(8), Anat Bashan(8), Raz Zarivach(7), Inna Levin(7), S. Weinstein(7), Laura J. V. Piddock(6), Sally Ellis(6), Ante Tocilj(5), Frank Schluenzen(5), Tamar Auerbach(5), Z. Berkovitch‐Yellin(5), William S. Bennett(5), Irit Sagi(5), Magnus Unemo(5), Joerg Harms(4)